Our Team

Big goals in the big apple

We come from different backgrounds, but we share the same belief: that science can change the world for the better. We exist to deliver life-saving cancer therapies through breakthroughs in drug discovery.

Our bios recount our academic credentials and professional achievements, but there’s a lot more to us. Our individual experiences shape who we are as a team, and together we’re passionate about making a difference.

We are supported by a premier group of investors and board members with a proven track record of building successful biotechnology companies. Our founders and scientific advisors are renowned for their seminal discoveries in cancer biology.

Charles Hugh-jones, M.D., FRCP

Chief Executive Officer

Rachel Zolot Schwartz, MBA

Chief Business Officer

Scott Drutman, M.D., Ph.D.

Chief Medical Officer

Sandi Peterson, Chair

Operating Partner
Clayton, Dubilier & Rice

Amy Schulman

Managing Partner
Polaris Partners

Samuel Bakhoum, M.D., Ph.D.

Assistant Member
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center

Arjun Balar, MD

Senior Vice President – Global Clinical Development
Lilly

Luc Dochez, Pharm.D.

Partner
DROIA Oncology Ventures

Charles Hugh-Jones, M.D, FRCP

Chief Executive Officer
Volastra Therapeutics

Stefan Vitorovic

Co-Founder and Managing Director
Vida Ventures

Lewis Cantley, Ph.D. (Chair)

Professor of Cell Medicine and Faculty Member
Dana Farber Cancer Center
Professor of Cell Biology
Harvard Medical School

Samuel Bakhoum, M.D., Ph.D.

Assistant Member
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center

David Baltimore, Ph.D.

President Emeritus and Distinguished Professor of Biology
California Institute of Technology

Duane Compton, Ph.D.

Dean
Geisel School of Medicine, Dartmouth College

Olivier Elemento, Ph.D.

Director of the Englander Institute for Precision Medicine
Weill Cornell Medicine

Gerard Evan, FRS, FMedSci

Professor of Cancer Biology
King's College London
Principal Group Leader
Francis Crick Institute

Tarun Kapoor, Ph.D.

PELS Family Professor
Rockefeller University

David Pellman, M.D.

Margaret M. Dyson Professor of Pediatric Oncology
Dana-Farber Cancer Institute

Nicholas A. Saccomano, Ph.D.

Independent Advisor/Board Member
Former CSO Array Biopharma, Former SVP-CSO Pfizer Boulder

Karen Vousden, Ph.D.

Chief Scientist
Cancer Research UK

Shinsan Michael Su, Ph.D.

Independent Advisor
Former CSO, Volastra Therapeutics
droia
vida